Synageva (GEVA) Underwriters Exercise Overallotment; Net Proceeds of $84M Expected

Synageva BioPharma Corp. (Nasdaq: GEVA), has announced the closing of a $90 million underwritten public offering of 3,574,266 shares of a common stock, including 466,209 shares of common stock which were issued pursuant to the exercise of the underwriters’ over-allotment option, at a price of $25.18 per share.

Synageva received net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $84 million from the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Treasure Global sells shares in two deals worth $6.6M total
• Greenland Mines announces 1-for-50 reverse split, field updates
• CBAK Energy expands Nanjing battery cell capacity toward 18 GWh